BFA 2015-2016 Senior Show Catalog

Carnation Pink - design - Kat Ashford What If - design - Noah Schrader Weekend Warrior - design - Olivia Kincaid Variant - design - Brianna Babcock Rockhounder - design - James McCahon Jemika (Jessica, Michelle, Katherine) - design - Jessica Guerra Driving Fast Car - photography - Chris Rasmussen The House that I Grew Up In, Of Which I Often Dream - design - Lex Aquilina Rational But Not Animal - design - Ryan Cook Uncharted Territory - design - Jessica Byrd Earthly Soles - design - Robyn Barta Eulogy - drawing - Arlene Cortes Mahalo Come Again - design - Haylee Soma Way of the Mind - drawing - Jacob Lucca Foreign Exchange - design - Grace Pan Unidentified Species - drawing - Gabriel Voris Following Cairn - design - Sydney Hallman Bear with One Another - sculpture - Ellen Cambruzzi Jayden - photography - Stella Sim Until Trees Sing - painting - Hannah Brown Fruition - design - Leslie Chung Death or Rest - interdisciplinary - Sarah Sundberg Lethe - painting - Rachel Emenaker Hammer and Nail - design - John Griffith Heirlooms - Jenn Jenison Is This remembrance... - photography - Natalie Crane Bad Luck For A Long Time - sculpture - Allison Winters Excuse Me - photography - Rachel Malek Bleach Dry - design - Tyler Cash In You - drawing/painting - Choongman Lee Confession - design - Hannah Hughes Nonmonotonous - sculpture - Rachel Crichton Dark - design - Sarah Starck Book design concept by Melanie Kim.Book layout by Melanie Kim and Chad Swanson.https://digitalcommons.biola.edu/exhibit-catalogs/1005/thumbnail.jp

Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients The ENDORSE Global Survey

Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis use in hospitalised medically ill patients. We analysed data from the global ENDORSE survey to evaluate VTE risk and prophylaxis use in this population according to diagnosis, baseline characteristics, and country. Data on patient characteristics, VIE risk, and prophylaxis use were abstracted from hospital charts. VTE risk and prophylaxis use were evaluated according to the 2004 American College of Chest Physicians (ACCP) guidelines. Multivariable analysis was performed to identify factors associated with use of ACCP-recommended prophylaxis. Data were evaluated for 37,356 hospitalised medical patients across 32 countries. VIE risk varied according to medical diagnosis, from 31.2% of patients with gastrointestinal/hepatobiliary diseases to 100% of patients with acute heart failure, active noninfectious respiratory disease, or pulmonary infection (global rate, 41.5%). Among those at risk for VTE, ACCP-recommended prophylaxis was used in 24.4% haemorrhagic stroke patients and 40-45% of cardiopulmonary disease patients (global rate, 39.5%). Large differences in prophylaxis use were observed among countries. Markers of disease severity, including central venous catheters, mechanical ventilation, and admission to intensive care units, were strongly associated with use of ACCP-recommended prophylaxis. In conclusion, VIE risk varies according to medical diagnosis. Less than 40% of at-risk hospitalised medical patients receive ACCP-recommended prophylaxis. Prophylaxis use appears to be associated with disease severity rather than medical diagnosis. These data support the necessity to improve implementation of available guidelines for evaluating VIE risk and providing prophylaxis to hospitalised medical patients